Title: Developing Quality Assurance Tools For Proton Beam Therapy
Funder: Science and Technology Facilities Council

Abstract: Modern cancer treatment is largely a combination of 3 techniques: surgery, chemotherapy and radiotherapy. Radiotherapy uses beams of X-rays to irradiate the tumour from many different directions. The effect is to kill the cancer by depositing as much radiation dose in the tumour as possible, whilst minimising the dose to the surrounding area to spare healthy tissue. Proton therapy is a more precise form of radiotherapy that provides significant benefits over conventional X-ray radiotherapy. Protons lose energy - and therefore deposit their dose - in a much smaller region within the body, making the treatment much more precise: this leads to a more effective cancer treatment with a smaller chance of the cancer recurring. This is particularly important in the treatment of deep-lying tumours in the head, neck and central nervous system, particularly for children whose bodies are still developing and are particularly vulnerable to long-term radiation damage. The advantages of proton therapy, coupled to the reduced cost of the equipment, has led to a surge in interest in proton therapy treatment worldwide: there are now over 20 centres, with this number set to double every 3 years over the next decade. The UK is currently constructing 2 full-sized proton therapy centres, to be based at University College Hospital in London and The Christie in Manchester and funded by the NHS. These will provide treatment for a much wider range of cancers, allowing more patients to be treated closer to home. Treating these cancers requires machinery that is significantly more complex than a conventional radiotherapy system. Protons are accelerated to the right energy for treatment by a particle accelerator: once the beam leaves the accelerator, it then has to be transported to the treatment rooms many metres away by a series of steering and focussing magnets. When the proton beam reaches the treatment room, it has to be delivered through a gantry to the correct place. Proton therapy gantries are enormous - more than 3 storeys tall and weighing more than a hundred tonnes - and have to rotate around the patient to deliver the beam from any angle with millimetre precision. In order to ensure that treatment with such complex machinery is carried out safely, a range of quality assurance (QA) procedures are carried out each day before treatment starts. The majority of this time is spent verifying that the proton beam travels the correct depth and is carried out for several different energies: protons are counted at different depths in a plastic block that resembles human tissue. These QA measurements of the proton range take significant time to set up and adjust for different energies: the full procedure can take over an hour. A detector is currently under development at UCL to provide faster and more accurate proton range measurements to speed up the daily QA process. UCL is working with Cosylab, the world's leader in control systems for proton therapy, to develop the electronics for this detector, as well as the software that is necessary to reconstruct the proton range measured by the detector. In addition, by taking advantage of Cosylab's expertise in the software needed to control modern clinical proton therapy centres, it will be possible to operate and monitor the detector from the main treatment control system, making it easier to make the QA measurements. Also, with over a decade of experience in producing commercial clinical devices, Cosylab will guide the development of the complete detector in order to make sure that it achieves the necessary medical and regulatory approval.


Research activity codes: 5.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES
Health categories: CANCER AND NEOPLASMS